Clinical application of laparoscopic pectopexy in the treatment of pelvic organ prolapse: efficacy and safety Authors: Panpan Hai, Yanpeng Tian, Liling Wang, Shuping Yan, Ye Zhang, Qian Wang, Qian Zhao, Ruixia Guo Published: 2025 ABSTRACT ObjectiveTo evaluate the efficacy and safety of laparoscopic pectopexy in the treatment of female pelvic organ prolapse (POP).MethodsA total of 40 patients with anterior and/or apical compartment prolapse who underwent laparoscopic pectopexy at the First Affiliated Hospital of Zhengzhou University from January 2022 to June 2023 were included in this retrospective study. Clinical data and outcomes were collected and analyzed. Pelvic Organ Prolapse Quantification (POP-Q), patients global impression of improvement (PGI-I), pelvic floor distress inventory-20 (PFDI-20), pelvic organ prolapse/urinary incontinence sexual questionnaire-12 (PISQ-12), and generalized anxiety disorder 7-item (GAD-7) scale were applied to evaluate the subjective and objective response by postoperative quality of life and sexual function. Intraoperative and postoperative complications were also analyzed to evaluate surgical safety.ResultsAll the 40 patients successfully completed the operation without intraoperative complications. During regular follow-up, one case had urinary retention after the operation, one case (2.5%) had mesh exposure and two cases (5.0%) had chronic pelvic pain. The objective and subjective response rates were 97.5% and 90% at 3 months after operation, 87.5% and 87.5% at 12 months after operation, respectively. The scores of PISQ-12, PFDI-20, and GAD-7 at 12 months after operation were significantly improved when compared with those before operation (P < 0.05).ConclusionLaparoscopic pectopexy is an alternative safe and effective surgical approach for the treatment of POP with anterior and apical pelvic defects. This surgical approach effectively restore the pelvic anatomy, and significantly improved quality of life and sexual function. Introduction Pelvic organ prolapse (POP) is a common and complex benign pelvic floor dysfunction disorder which caused by pelvic floor support defects [1]. Previous study indicated the incidence of POP was 3.40% to 10.76% among US racial populations [2]. In Chinese population, the POP prevalence rates ranged from 4.78 to 28.21% [3]. POP refers to prolapse of the anterior compartments prolapse, apical compartments prolapse, and posterior compartments prolapse. There are a variety of symptoms associated with POP, including prolapse sensation, pelvic pain, urinary incontinence, and difficulty voiding, vaginal pain and sexual dysfunction. In addition, previous studies indicates that the burden of climacteric symptoms and economy for patients is higher with POP than without it [4]. With the increase of the number of elderly women, the incidence rate of pelvic organ prolapse is expected to further increase, which makes the understanding and management of POP become particularly important [5]. Treatment modalities for POP encompass a range of both surgical and non-surgical options. Non-surgical treatments often include the use of pessaries, which can provide symptomatic relief without the need for invasive procedures. However, surgical intervention is frequently required for more severe cases or when non-surgical methods fail to alleviate symptoms. Surgical treatment options for POP are diverse and can be tailored to the individual patient's needs. Traditional surgical option is hysterectomy with anterior/posterior colporrhaphy. The high recurrence rates restricts its clinical application [6]. In the treatment of apical prolapse, sacral colpopexy was regarded as the gold standard approach [7–9]. However, the complex anatomy of sacral area makes the surgery challenging, especially in obese patients or with anatomical variations, which may result in severe nerve, ureteral, and even fatal vascular injuries. In 2011, pectopexy was first reported and gradually applied in treatment of apical compartments prolapse [10]. Compared with sacral colpopexy, previous indicated that pectopexy has the advantages of low trauma, simplicity, and significant therapeutic effects [10, 11]. Therefore, pectopexy could be an alternative surgical option. In this study, we aimed to analyzed clinical data and outcomes of POP patients, who underwent laparoscopic pectopexy to evaluate its efficacy and safety. Methods and materials Ethical approval Ethical approval were obtained from the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2024-KY-1859-001). Written informed consent was obtained from all patients. Study participants This research was a single-center retrospective study conducted by Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University from January 2022 to June 2023. A total of 40 patients who underwent laparoscopic pectopexy were enrolled in this study. Inclusion criteria were as follows: (1) patients diagnosed with anterior prolapse (POP-Q stage Ⅱ or above) with or without apical prolapse; (2) Patients with good postoperative compliance and who can be followed up on time. Exclusion criteria are as follows: (1) patients with gynecological malignant tumors; (2) patients with sever complications who were unable to tolerate surgery; (3) patients with posterior compartments prolapse with stage Ⅲ or above by POP-Q staging. Surgical procedure All patients receive standard vaginal and abdominal preparation prior to surgery. The surgeries were performed by the same experienced gynecologists. A Foley catheter was used to continuously drain the bladder throughout the surgery. Laparoscopy was placed into the abdominal cavity as previous studies reported [11, 12]. For patients opting for uterus removal, a laparoscopic hysterectomy was carried out using standard procedures. Before surgery, we informed the risk of hysterectomy in detail and hysterectomy was performed based on the patients’ own will. Upon completion of hysterectomy, single-layer continuous Vicryl 1–0 stitch was used to close the vaginal cuff. For those patients opting for uterine-preserving, the peritoneum between the uterus and bladder, and the anterior lobe of the broad ligament were opened to adequately expose the anterior vaginal wall. The mid-section of mesh (GYNECARE GYNEMESH PS Nonabsorbable PROLENE Soft Mesh, Johnson & Johnson, USA) was sutured to vaginal apex. Then, we open the superficial layer of the peritoneum between the round ligament and the medial umbilical ligament to expose the the iliopectineal ligaments. Both ends of mesh was stitched to the iliopubic ligaments. Afterward, we proceeded to close the peritoneal layer with absorbable sutures. The decision to conduct an anterior or posterior vaginal repair simultaneously depended on the extent of prolapse before surgery. The surgical procedures were showed in the Fig. 1.Fig. 1A Open the peritoneum between the uterus and bladder to expose the anterior vaginal wall. B Open the the superficial layer of the peritoneum between the round ligament and the medial umbilical ligament to expose the the iliopectineal ligaments. C, D The middle of the mesh is fixed to the anterior wall of the cervix. E Both ends of mesh was stitched to the iliopubic ligaments. F Close the peritoneal layer with absorbable sutures A Open the peritoneum between the uterus and bladder to expose the anterior vaginal wall. B Open the the superficial layer of the peritoneum between the round ligament and the medial umbilical ligament to expose the the iliopectineal ligaments. C, D The middle of the mesh is fixed to the anterior wall of the cervix. E Both ends of mesh was stitched to the iliopubic ligaments. F Close the peritoneal layer with absorbable sutures Clinical outcome measures The clinical outcome measures included operative time, urethral Foley catheter retention time, intraoperative blood loss, postoperative hospital stay. Patients Global Impression-Improvement (PGI-I) were assessed at 3 months and 12 months after surgery. Pelvic Organ Prolapse Quantification (POP-Q), pelvic Floor Distress Inventory-20 (PFDI-20), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12), and Generalized Anxiety Disorder 7-item (GAD-7) scale were assessed before surgery, 3 months and 12 months after surgery. Objective recurrence was defined as beyond the hymen via gynecological examination. Statistics These clinical data were collected and analyzed by SPSS version 24.0. The enumeration data are presented in percentage. Continuous variables that have a normal distribution are presented as means ± standard deviation and comparison were performed using paired t -test. Variables without a normal distribution are presented as medians (interquartile ranges) and comparisons were performed using Wilcoxon test. P < 0.05 was considered as significantly difference. Results A total of 40 POP patients were enrolled in this study. All patients had anterior compartments prolapse and apical compartments prolapse, of whom 23 patients had posterior compartments prolapse. The average age of the 40 patients was 50.28 ± 10.23 years, ranging from 32–65 years. The average BMI was 24.94 ± 2.95 kg/m2 (range from 20.5–30.9 kg/m2). Of these patients, 20 patients was menopausal. Detailed clinical information and POP-Q staging are shown in Table 1. Table 1The general clinical data of patientsVariablesX ± s or n (%)Age (Year, X ± s)50.28 ± 10.23BMI (kg/m2, X ± s)24.94 ± 2.95Number of deliveries [M, (Q1, Q3)]2 (2, 2)Menopause (n, %)20 (50%)Uterine prolapse (n, %) I1 (2.5%) II27 (67.5%) III12 (30%) IV0 (0%)Anterior compartments prolapse (n, %) I0 (0%) II17 (42.5%) III22 (55.0%) IV1 (2.5%)Posterior compartments prolapse (n, %) I11 (27.5%) II12 (30.0%) III0 (0%) IV0 (0%) Table 1The general clinical data of patientsVariablesX ± s or n (%)Age (Year, X ± s)50.28 ± 10.23BMI (kg/m2, X ± s)24.94 ± 2.95Number of deliveries [M, (Q1, Q3)]2 (2, 2)Menopause (n, %)20 (50%)Uterine prolapse (n, %) I1 (2.5%) II27 (67.5%) III12 (30%) IV0 (0%)Anterior compartments prolapse (n, %) I0 (0%) II17 (42.5%) III22 (55.0%) IV1 (2.5%)Posterior compartments prolapse (n, %) I11 (27.5%) II12 (30.0%) III0 (0%) IV0 (0%) The general clinical data of patients All patients successfully underwent laparoscopic pectopexy, of whom 11 patients underwent laparoscopic hysterectomy in the mean time. There were no surgical complications observed in the intraoperative period. The average overall operative time was 146.63 ± 30.22 min (range 78–192 min). The average estimated intraoperative blood loss was 20 ml (range 5–50 ml). The median indwelling time of urinary catheter was 3 days (interquartile range, 2–3 days). The median postoperative length of hospital stay was 5 days (interquartile range, 4–6 days). One patient presented with urinary retention who had the catheter removed on the 2nd day after surgery. Thus, the patient had undergone indwelling urinary catheter again and had the catheter removed on the 6th day after surgery. One patient presented fever on the 2nd day after surgery, which improved after treatment. During follow-up, 2 (5%) patients presented with chronic pelvic pain, and 1 patient presented mesh exposure 3 months after surgery. Results are showed in Table 2. Table 2Perioperative outcomes and postoperative complicationsVariablesX ± s or n (%)Perioperative outcomes Operative time (min, x ± s)146.63 ± 30.22 Intraoperative bleeding volume [ml, M (Q1, Q3)]20 (20, 30) Indwelling time of the urethral Foley catheter [d, M (Q1, Q3)]3 (2, 3) Postoperative hospital stay [d, M (Q1, Q3)]5 (4, 6)Postoperative complications Fever (n, %)1 (2.5%) Urinary retention (n, %)1 (2.5%) Chronic pelvic pain (n, %)2 (5.0%) Mesh exposure (n, %)1 (2.5%) Table 2Perioperative outcomes and postoperative complicationsVariablesX ± s or n (%)Perioperative outcomes Operative time (min, x ± s)146.63 ± 30.22 Intraoperative bleeding volume [ml, M (Q1, Q3)]20 (20, 30) Indwelling time of the urethral Foley catheter [d, M (Q1, Q3)]3 (2, 3) Postoperative hospital stay [d, M (Q1, Q3)]5 (4, 6)Postoperative complications Fever (n, %)1 (2.5%) Urinary retention (n, %)1 (2.5%) Chronic pelvic pain (n, %)2 (5.0%) Mesh exposure (n, %)1 (2.5%) Perioperative outcomes and postoperative complications No patients were reported objective recurrence 3 months after surgery. Three patients experienced objective recurrence 12 months after surgery, of whom 1 patients presented anterior prolapse (POP-Q stage Ⅱ), 1 patient presented posterior prolapse (POP-Q stage Ⅱ), and 1 patient presented anterior prolapse and posterior prolapse (POP-Q stage Ⅱ). All three patients were considered as recurrence by gynecological examinations. However, none of the three patients were symptomatic and underwent operational intervention again. Subjective success rates were all 100%, respectively at 3 months, and 12 months after surgery. Results are showed in Table 3. All patients had regular sexual intercourse at 6 months after surgery. The scores of PISQ-12, PFDI-20, and GAD-7 were assessed at preoperative 12 months after surgery. Results indicated the quality of life was significantly improved than that before surgery. These results are showed in Table 4. Table 3Clinical outcomes and postoperative follow-up of patientsVariables3 months after surgery (n = 40) (n, %)12 months after surgery (n = 40) (n, %)General recurrence rate0 (0%)3 (7.5%)Sites of recurrence Anterior compartments0 (0%)1 (2.5%) Posterior compartments0 (0%)1 (2.5%) Apical compartments0 (0%)0 (0%) Anterior and posterior compartments0 (0%)1 (2.5%)PGI-I success rate40 (100%)40 (100%)Very much improved32 (80%)31 (77.5%) Much improved8 (20%)9 (22.5%) Minimally improved0 (0%)0 (0%) Not change0 (0%)0 (0%) Minimally worse0 (0%)0 (0%) Much worse0 (0%)0 (0%) Very much worse0 (0%)0 (0%)PGI-I success defined as “very much improved” or “much improved”. Objective recurrence was defined as beyond the hymenTable 4PFDI-20, PISQ-12, GAD-7 score at preoperative and 12 months after surgeryVariablesPreoperative12 months after surgeryPPFDI-2079.17 (67.71, 113.55)19.79 (13.80, 28.13) < 0.001 POPDI-645.83 (37.5, 67.71)8.33 (4.17, 12.5) < 0.001 CRADI-89.38 (9.38, 15,63)3.13 (3.13, 3.91) < 0.001 UDI-625 (20.83, 39.58)8.33 (4.17, 12.5) < 0.001PISQ-1217 (15, 19.25)29 (25, 31) < 0.001 Emotional5.5 (5, 6.25)10.5 (9, 12) < 0.001 Physical7 (7, 8)12 (11, 13) < 0.001 Partner-related5 (3.75, 6)6 (4, 7) < 0.001GAD-76.5 (4, 9)2 (1.75, 3) < 0.001PFDI-20: Pelvic Floor Distress Inventory-20; POPDI-6: Pelvic Organ Prolapse Distress Inventory-6; CRADI-8: Colorectal-Anal Distress Inventory-8; UDI-6: Urinary Distress Inventory-6; PISQ-12: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12; GAD-7 Generalized Anxiety Disorder-7 Table 3Clinical outcomes and postoperative follow-up of patientsVariables3 months after surgery (n = 40) (n, %)12 months after surgery (n = 40) (n, %)General recurrence rate0 (0%)3 (7.5%)Sites of recurrence Anterior compartments0 (0%)1 (2.5%) Posterior compartments0 (0%)1 (2.5%) Apical compartments0 (0%)0 (0%) Anterior and posterior compartments0 (0%)1 (2.5%)PGI-I success rate40 (100%)40 (100%)Very much improved32 (80%)31 (77.5%) Much improved8 (20%)9 (22.5%) Minimally improved0 (0%)0 (0%) Not change0 (0%)0 (0%) Minimally worse0 (0%)0 (0%) Much worse0 (0%)0 (0%) Very much worse0 (0%)0 (0%)PGI-I success defined as “very much improved” or “much improved”. Objective recurrence was defined as beyond the hymen Clinical outcomes and postoperative follow-up of patients PGI-I success defined as “very much improved” or “much improved”. Objective recurrence was defined as beyond the hymen Table 4PFDI-20, PISQ-12, GAD-7 score at preoperative and 12 months after surgeryVariablesPreoperative12 months after surgeryPPFDI-2079.17 (67.71, 113.55)19.79 (13.80, 28.13) < 0.001 POPDI-645.83 (37.5, 67.71)8.33 (4.17, 12.5) < 0.001 CRADI-89.38 (9.38, 15,63)3.13 (3.13, 3.91) < 0.001 UDI-625 (20.83, 39.58)8.33 (4.17, 12.5) < 0.001PISQ-1217 (15, 19.25)29 (25, 31) < 0.001 Emotional5.5 (5, 6.25)10.5 (9, 12) < 0.001 Physical7 (7, 8)12 (11, 13) < 0.001 Partner-related5 (3.75, 6)6 (4, 7) < 0.001GAD-76.5 (4, 9)2 (1.75, 3) < 0.001PFDI-20: Pelvic Floor Distress Inventory-20; POPDI-6: Pelvic Organ Prolapse Distress Inventory-6; CRADI-8: Colorectal-Anal Distress Inventory-8; UDI-6: Urinary Distress Inventory-6; PISQ-12: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12; GAD-7 Generalized Anxiety Disorder-7 PFDI-20, PISQ-12, GAD-7 score at preoperative and 12 months after surgery PFDI-20: Pelvic Floor Distress Inventory-20; POPDI-6: Pelvic Organ Prolapse Distress Inventory-6; CRADI-8: Colorectal-Anal Distress Inventory-8; UDI-6: Urinary Distress Inventory-6; PISQ-12: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12; GAD-7 Generalized Anxiety Disorder-7 Discussion Previous studies have indicated that anterior compartments prolapse is the most common in POP, and the apical compartments prolapse often arise together in clinical investigations. The unadequate support of apical compartments is the important factor of the failure of anterior and posterior vaginal repairs [13, 14]. Studies had confirmed that sacralcolpopexy had a lower recurrence rate and was considered as the gold standard surgical modality for apical compartments prolapse [15, 16]. However, with continuous clinical practice, the limitations of sacralcolpopexy surgery have also been revealed, such as difficulty in exposing the sacral anterior region, suturing the mesh, long learning curve, and multiple complications [17]. Therefore, we hope to investigate a potential surgical strategy for POP. Recent years, laparoscopic pectopexy was applied in treatment of POP and had promising therapeutic benefits for POP patients [11, 18]. In this study, we retrospectively analyzed clinical data and outcomes of 40 patients who underwent laparoscopic pectopexy to evaluate its efficacy and safety. All patients had anterior compartments prolapse and apical compartments prolapse, of whom 23 patients had posterior compartments prolapse. All general clinical characteristics were showed in Table 1. Based on the results, anterior compartments prolapse and apical compartments prolapse are the most common POP. These results are consistent with previous studies reported that the apical compartments prolapse often arise together with anterior/posterior compartments prolapse in clinical investigations. All patients underwent laparoscopic pectopexy, of whom 11 patients underwent laparoscopic hysterectomy in the mean time. There were no surgical complications observed in the intraoperative period. Overall. 12.5% (5/40) of patients presented postoperative complications. Two patients presented with chronic pelvic pain and one patient presented with mesh exposure. Although complication rates seems in a high level, the results might be biased due to the small sample size. In terms of surgical complications, previous studies reported that the overall postoperative compilation rate was 0–27.3% and that severe complication rate was less than 5% [19–22]. Paulina et al. analyzed 60 patients who underwent laparoscopic pectopexy, and found that only one patient with a history of hysterectomy experienced intestinal injury, with a severe complication rate of less than 1.7% [19]. Another study by Tahaoglu et al. reported that 1 out of 22 patients who had underwent laparoscopic pectopexy experienced intraoperative bleeding due to severe pelvic adhesions [22]. In this study, 1 patient presented with urinary retention after surgery. It might be related to anterior compartments prolapse and anterior colporrhaphy. Chronic pelvic pain and mesh exposure might be related to immune rejection and alterations to pelvic anatomy following surgery. In addition, pelvic surgery also can lead to pelvic pain. Mesh exposure is a severe long-term postoperative complication. In this study, only one patient presented mesh exposure. With topical application of estrogen, the mesh exposure was healing. Mesh, as a foreign body, can lead to sever inflammatory immune response and immune injection, which might lead to mesh exposure. In addition, mesh exposure is also related to the surgeon’s experience and suture technique [23]. To avoid mesh exposure, the surgery should be performed experienced surgeon. Application of estrogen might be beneficial in reducing the risk of mesh exposure. To investigate the efficacy of laparoscopic pectopexy, we followed up patients up to 12 months. The subjective success rate was 100% and the objective success rate was 92.5%. One year after surgery, only three patients experienced recurrence which were found at gynecological examinations. Patients have no obvious discomfort symptoms and only experience prolapse during breath-hold. Even though experiencing mild recurrence, the symptoms and quality of life were significantly improved when compared with the preoperative levels based on PGI-I. Therefore, outcomes of these patients is still assessed subjective success. These results indicates that laparoscopic pectopexy for the treatment of POP has a good therapeutic efficacy. Previous study showed that laparoscopic pectopexy had a similar success rates with laparoscopic sacral colpopexy. However, the laparoscopic pectopexy was associated with shorter surgical time and lower PFDI-20 score than laparoscopic sacral colpopexy [24]. Kale et al. reported that the success rate of laparoscopic pectopexy was 100% after six months of postoperative follow-up [25]. Obut et al. reported a case series of 32 patients who underwent laparoscopic pectopexy. After 1 year follow-up, only 1 out of 32 patients experienced recurrence [26]. In this study, the PFDI-20、PISQ-12、GAD-7 scores were significantly improved compared to their pre-operative values. All these results indicated that laparoscopic pectopexy might be a potential surgical procedure for POP. In addition, more than half of the patients in the study opted for a uterine-preserving surgery. The recurrence rate in uterine-preserving patients is 3.4% (1/29). The recurrence rate is 18.2% (2/11) in patients undergoing hysterectomy. Only 1 mesh exposure occurred in patients undergoing hysterectomy. It seems that uterine-preserving might not increase the risk of recurrence and might decrease the risk of mesh exposure. Due to limited sample size, it still needs further investigation. However, our previous study indicated that equally satisfactory long-term outcomes had achieved after laparoscopic uterosacral suspension with or without hysterectomy. Therefore, uterine-preserving might be feasible in pelvic reconstruction. These also indicates that uterine-preserving surgery is feasible for those patients who wish to preserve the uterus. The low rate of mesh exposure in uterine-preserving patients may be due to the preservation of the integrity of the vaginal vault, which reduces the risk of mesh infection and exposure. The preserved cervix may provide additional structural support for mesh and suture attachment, while the complete pelvic vascular anatomy ensures sufficient blood supply to the vaginal apex, thereby improving local healing and reducing the risk of mesh exposure [27, 28]. It still need further investigation to verify. Strengths of the study should be addressed. The feasibility and safety of was comprehensively evaluated via perioperative indexes and postoperative complications. Long term follow-up was performed to evaluated the outcomes. All these results confirmed laparoscopic pectopexy is a potential surgical procedure for POP. Even though we highlight a series of significant outcomes, this study still has some limitations. First, the sample size in the study was small, which may lead to bias. Second, this is a retrospective study, and there are many factors of bias and uncontrollable factors. Then, we did not perform the priori power analysis. It might be lead to statistical bias. Finally, there was no control group. Laparoscopic sacral colpopexy is known as the the standard procedure for POP. In this study, we did not set a control group such as laparoscopic sacral colpopexy, which might lead to limit these findings. In future, we will design a multi-center randomized controlled trial with large sample size to investigate the outcomes of different surgical procedures. In recent years, stem cells and biomaterials has been applied to tissue repairing and regeneration and pelvic floor reconstruction surgery [29, 30]. Such studies are still at the stage of in vitro tests and animal experiments. However, biomaterials and hydrogels might still provide a potential treatment approach [31]. In future, we hope biomaterials and tissue engineering will apply in the pelvic reconstruction surgery. In conclusion, laparoscopic pectopexy is a potential surgical procedure for POP, especially for those with anterior and apical compartments prolapse. Long-term outcomes of laparoscopic pectopexy still needs further investigation.